Flora Peyvandi / X
Jun 26, 2025, 12:53
Flora Peyvandi: Chinese Researchers Smoothly Enter the Gene‑Therapy Arena as the Fight for Hemophilia B Heats Up
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, posted on X:
”First Chinese HB gene therapy: ISTH2025”
They say it’s better to prevent than treat—so naturally, ISTH 2025 turned into a gene‑therapy playground for Hemophilia B.
The clinical gene sessions are serving up some seriously insightful management intel!
Stay updated on the latest breakthroughs in Hematology: Hemostasis Today.
-
Jan 10, 2026, 15:15Stefan Gerner on Stroke Care and Subarachnoid Hemorrhage
-
Jan 10, 2026, 15:02Dr Manikanta Receives AHA Fellowship to Investigate Platelet-Dependent Nucleic Acid-Sensing Pathways
-
Jan 10, 2026, 14:40Last day at ASH25 from Riten Kumar
-
Jan 10, 2026, 08:56Shivanand Kumatagi Reflects on His Visit to Rela Hospital
-
Jan 10, 2026, 08:48Mitchell Elkind: Why Is The American Heart Association Holding a Brain Health Symposium?
-
Jan 10, 2026, 08:41Fiona Robinson Invites You to NBDF Webinar on Research Grants
-
Jan 10, 2026, 08:30Melissa Korn Takes Front Page Award for Her WSJ Piece on Experiencing a Pulmonary Embolism
-
Jan 10, 2026, 08:20Aymar Akilimali on Malaria in the Democratic Republic of Congo
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council